MDD: Clinical Trials

2 trials for MDD, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2

Follow MDD: new trials by email Literature Review of MDD trials Research Report on MDD

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Active Adults, 18 to 35 Years Old, With Major Depressive Disorder Who Are in a School or Work Environment
Brexpiprazole - MDD
Phase 3CompletedOtsuka Pharmaceutical Development & Commercialization, Inc.482013-11-012016-03-29
A Study to Assess the Long- Term Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder
TC-5214, Placebo - Major Depressive Disorder, MDD
Phase 3CompletedAstraZeneca8132010-06-012014-04-11

Narrower conditions

Depressive Disorder, Major (2)  ·  Anxiety Disorders (1)  ·  Depression (1)  ·  Mental Disorders (1)  ·  Psychotic Disorders (1)  ·  Schizophrenia (1)

Broader conditions

Depressive Disorder (2)  ·  Mood Disorders (2)  ·  Behavior (1)  ·  Behavioral Symptoms (1)  ·  Mental Disorders (1)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (1)

Interventions

brexpiprazole (1)

Sponsors

AstraZeneca (1)  ·  Otsuka Pharmaceutical Development & Commercialization, Inc. (1)

Countries

United States (2)  ·  Puerto Rico (1)

Top investigators

Andrew . J Cutler, MD (1)  ·  Hans A. Eriksson, MD, Ph.D, MBA (1)  ·  Junichi Hashimoto, PhD (1)

Results publications

PMID 25514064, PMID 34894307